Tweet
Neonatal intensive care cot worth of 9 thousand pounds sterling
acquired for Medical Research Center for Maternal and Child Health
Protection in Yerevan
2009-01-17 12:37:00
ArmInfo. VivaCell-MTS, a subsidiary of Mobile TeleSystems OJSC (NYSE:
MBT), announces the official hand over ceremony of neonatal intensive
care cot worth of 9 thousand pounds sterling to the Medical Research
Center for Maternal and Child Health Protection. VivaCell-MTS
press-service told ArmInfo that the equipment for intensive therapy
from now on will be used for improving the condition of sickly and weak
infants increasing their chances of survival and will eventually result
in a major decrease in childhood mortality.
As a responsible corporate citizen VivaCell-MTS pays huge attention to
health care for children and mothers. The special modern baby intensive
care cot purchased will help achieve improved health
outcomes in the context of ill children.
"Children's health needs must be addressed as we must care for our
future today. VivaCell-MTS is dedicating its CSR activities in 2009 to
children under the title "VivaCell-MTS to Children". Our projects
will target children's needs on all levels. Handing over this important
equipment is a worthwhile and promising program that fits comfortably
into our overall activity in the sphere of CSR for year 2009 to the
benefit of the children of Armenia. Children are the flowers of our
life and their health is truly important. Their happy and healthy life
is everyone's issue, and therefore it deserves the public's
full-fledged support", - noted VivaCell-MTS General Manager Ralph
Yirikian.
From: Emil Lazarian | Ararat NewsPress
acquired for Medical Research Center for Maternal and Child Health
Protection in Yerevan
2009-01-17 12:37:00
ArmInfo. VivaCell-MTS, a subsidiary of Mobile TeleSystems OJSC (NYSE:
MBT), announces the official hand over ceremony of neonatal intensive
care cot worth of 9 thousand pounds sterling to the Medical Research
Center for Maternal and Child Health Protection. VivaCell-MTS
press-service told ArmInfo that the equipment for intensive therapy
from now on will be used for improving the condition of sickly and weak
infants increasing their chances of survival and will eventually result
in a major decrease in childhood mortality.
As a responsible corporate citizen VivaCell-MTS pays huge attention to
health care for children and mothers. The special modern baby intensive
care cot purchased will help achieve improved health
outcomes in the context of ill children.
"Children's health needs must be addressed as we must care for our
future today. VivaCell-MTS is dedicating its CSR activities in 2009 to
children under the title "VivaCell-MTS to Children". Our projects
will target children's needs on all levels. Handing over this important
equipment is a worthwhile and promising program that fits comfortably
into our overall activity in the sphere of CSR for year 2009 to the
benefit of the children of Armenia. Children are the flowers of our
life and their health is truly important. Their happy and healthy life
is everyone's issue, and therefore it deserves the public's
full-fledged support", - noted VivaCell-MTS General Manager Ralph
Yirikian.
From: Emil Lazarian | Ararat NewsPress